REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 1 filers reported holding REXAHN PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $2,937,000 | +322.6% | 5,758,391 | +17.6% | 0.00% | +300.0% |
| Q4 2016 | $695,000 | +3.4% | 4,896,391 | +52.9% | 0.00% | 0.0% |
| Q3 2016 | $672,000 | +13.5% | 3,201,993 | +35.9% | 0.00% | 0.0% |
| Q2 2016 | $592,000 | +6.5% | 2,355,593 | +39.7% | 0.00% | 0.0% |
| Q1 2016 | $556,000 | +20.9% | 1,685,795 | +33.1% | 0.00% | 0.0% |
| Q4 2015 | $460,000 | +6.0% | 1,266,400 | +51.6% | 0.00% | 0.0% |
| Q3 2015 | $434,000 | +24.0% | 835,400 | +45.0% | 0.00% | 0.0% |
| Q2 2015 | $350,000 | +65.1% | 576,100 | +98.8% | 0.00% | – |
| Q1 2015 | $212,000 | +96.3% | 289,800 | +87.0% | 0.00% | – |
| Q4 2014 | $108,000 | – | 154,986 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 20,000 | $57,000 | 0.02% |